VR Logo

Oxygenta Pharmaceutical: Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015And In Terms Of Aforesaid SEBI Circular Dated May 20 2020 And All Other Applicable Regulations And Closure Of Trading Window

Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 inter alia to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Friday 12th August 2022 inter-alia to consider and approve:1. The Un-audited Financial Results for the first quarter ended 30th June 2022:2. Other Corporate mattersAs per the provisions of the SEBI (Prohibition of Insider Trading) Regulations 2015 read with the Code of conduct to Regulate Monitor and Report Trading by insiders of the Company the Trading window for dealing in the equity shares of the Company was closed from 01st July 2022 till 48 hours after the declaration of financial results for the First quarter ended 30th June 2022 for all designated persons their immediate relatives and all connected persons covered under the said Code.This is for your information and records.

Click here to view PDF